|
|
|
|
|
by vparikh
1328 days ago
|
|
> There are key differences between an emergency and traditional model that increase the costs of making and distributing the COVID-19 vaccine,” Pfizer told Quartz via email. These costs, the company says, include distributing through multiple channels and payers instead of one, as well as producing the doses in single vials, which can be up to three times more expensive and run into higher transportation costs. Did Pfizer just admit that single payer systems are more economical than the privatized mess we have in the US???? |
|